Close your eyes and just think....when there is a over subscription why would you sell just for 20c when you could have got much more with good news to follow soon...why not hold till FDA approval and/or adult trial results and then CR at much higher price for commercialising/expanding etc ?
Which gives an impression that SP may have reached to its true value...and strong fundamental is already priced in...
Prospectus, page-140
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #